CLINICAL_TRIALS
trial_result
· 2022-08-09
Clinical Trial Update: Translating Neuroprediction Into Precision Medicine Via Brain Priming [Phase 2]
Summary
Phase 2 clinical trial in Autism Spectrum Disorder terminated; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Yale University | Conditions: Autism Spectrum Disorder | Phase 2 | Status: TERMINATED | Results posted: 2022-08-09